VAERS Explorer
Back to explore

Report #2879393

Received Dec 23, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
NC
Recovered
Unknown
Vaccinated
Jan 1, 2021
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (PFIZER-BIONTECH))PFIZER\BIONTECH2——

Symptoms (1)

Mastocytosis

Symptom narrative

cutaneous mastocytosis; This is a spontaneous report received from a Physician from medical information team. A male patient received BNT162b2 (BNT162B2), in Jan2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: MASTOCYTOSIS (non-serious) with onset 2021, outcome "unknown", described as "cutaneous mastocytosis". The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received. Additional information: Post covid vaccine causing cutaneous mastocytosis within one week after second covid vaccine in January, 2021.